Stock listing

Aclaris Therapeutics, Inc.

Selected listing: 8AT · TRADEGATE · EUR · DE

Aclaris Therapeutics, Inc. (Tradegate:8AT), Health Technology. Latest release Sep 3, 2026: Aclaris Therapeutics to Participate in the 2026 Cantor Global…

8AT:TRADEGATEEURDEUpdated October 2, 2026
Aclaris Therapeutics, Inc. logo
Ticker
Tradegate:8AT
Asset type
Stock
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
Tradegate
Currency
EUR

About Aclaris Therapeutics, Inc.

The company focuses on developing innovative therapies for dermatological conditions. Aclaris is committed to advancing its research and product pipeline to address unmet medical needs in the skin health sector.

Latest news from Aclaris Therapeutics, Inc.

All Aclaris Therapeutics, Inc. news →

Events

Replays

  • Aclaris Therapeutics, Inc. (ACRS) Q1 2024 Earnings Call

    Tue, May 07, 2024 · 05:00 PM ET

    Watch
  • Aclaris Therapeutics, Inc. (ACRS) Q1 2023 Earnings Call

    Mon, May 08, 2023 · 08:00 AM ET

    Watch

Research Aclaris Therapeutics, Inc.

Alternate listings